Gallensteine – prädisponierende Faktoren, Symptome, Risikofaktoren und ernährungsmedizinische Behandlung

The origins of cholelithiasis represent a multifaceted medical challenge whose comprehensive understanding necessitates an examination of metabolic disturbances affecting the lipid constituents of bile. Contemporary definitions characterize this condition as arising from imbalances in the relative concentrations of cholesterol, phospholipids, and bile acids, thereby precipitating crystallization and the formation of solid calculi. It is critical to emphasize that this pathology manifests throughout the biliary tract system, encompassing both intrahepatic structures (first- and second-order bile ducts) and extrahepatic components (common bile duct and gallbladder). From a clinical perspective, gallstones are categorized based on their chemical composition: pigment stones (primarily bilirubin-derived) and cholesterol stones, the latter of which frequently present in mixed form, incorporating additional calcium salts, bile pigments, and other organic sedimentary components.

In the vast majority of instances, gallstone disease remains clinically silent, with asymptomatic concretions that do not provoke pain or subjective discomfort in the affected individual. Symptomatic manifestations occur in approximately 25% of patients and may present in highly variable forms—ranging from mild digestive disturbances to severe, acute pain episodes. The onset of symptomatic gallstone disease is frequently marked by sudden, intense epigastric pain, particularly following the consumption of a large, high-fat meal, accompanied by gastrointestinal motility disorders. Nonspecific yet common symptoms include recurrent diarrhea, persistent heartburn, and gastroesophageal reflux disease, whose direct association with gallstones can be challenging to establish definitively. The most distinctive and pathognomonic feature is biliary colic—a sharp, steady pain localized in the right upper quadrant of the abdomen, typically lasting between two and five hours. In advanced stages of the disease, systemic symptoms such as persistent nausea, episodic vomiting, and a significant reduction in appetite may emerge, potentially indicating complications that necessitate medical evaluation and intervention.

A comprehensive analysis of the risk factors associated with gallstone disease: **Age** – The highest incidence occurs during middle age and early senescence; women over 35 are significantly more affected, whereas after age 70, the prevalence equalizes between genders, affecting approximately 45–50% of this demographic. **Female sex** – Women develop gallstones two to three times more frequently than men, particularly those with more than two children; progesterone enhances cholesterol secretion into bile and impairs gallbladder motility, with over one-third of women affected after age 60. **Oral hormonal contraception** – Especially when used irregularly, with interruptions, or initiated during adolescence (ages 14–19). **Obesity** – Particularly chronic and early-onset, with predominant visceral fat distribution. **Liver cirrhosis** – Doubles the likelihood of gallstone formation. **Metabolic disorders** – Diabetic neuropathy compromises gallbladder contractility, leading to bile stasis; reduced serum HDL cholesterol levels promote cholelithiasis. **Rapid weight loss** – Hypocaloric diets suppress cholecystokinin secretion, causing gallbladder contraction and bile congestion; this can be mitigated by incorporating small amounts of fat, which stimulates hormone production. **Pregnancy** – Each subsequent pregnancy increases risk by 2%, and in women who have given birth to four children by age 25, the risk rises to as high as 25%.

The dietary management of cholelithiasis necessitates the strict exclusion of all food items and culinary practices that provoke excessive biliary spasms or irritate the gallbladder mucosa. Among the most potent choleretic and spasmogenic agents are the following: egg yolks (exhibiting the highest contractile stimulus), high-fat dairy products such as heavy cream (≥30% fat) and clarified butter, lard, fatty meats (pork, lamb, goose), deep-fried foods (including fast-food items, potato chips, corn snacks), dark chocolate with high cocoa content, and pastries filled with fat-rich creams (layer cakes, doughnuts, éclairs). An optimal nutritional regimen for individuals with gallstones must prioritize dietary diversity while being precisely tailored to the patient’s energy requirements, current nutritional status, and physical activity levels. Engaging in regular, moderate exercise—such as walking, swimming, or yoga—exerts a beneficial effect on biliary motility, potentially delaying disease progression. Of paramount importance is an adequate intake of dietary fiber (both soluble and insoluble), as deficiencies significantly impair gallbladder contractility; only proper motility ensures efficient emptying of stagnant bile. A rigorous reduction in saturated and *trans* fats is mandatory, with a shift toward unsaturated fatty acids (omega-3 and omega-6). Preferred protein sources include lean poultry (skinless turkey or chicken), marine fish (cod, pollock, pike-perch), low-fat dairy products (0.5% milk, kefir, buttermilk), nonfat cottage cheese, and reduced-fat granular cheeses. Consuming five small, evenly spaced meals throughout the day helps prevent abrupt gallbladder contractions triggered by large portions. An often-overlooked yet critical component is *meal hygiene*: eating slowly in a calm environment with thorough mastication of each bite. Permissible cooking techniques include boiling in water or steaming, baking in aluminum foil/parchment paper with extra-virgin olive oil or cold-pressed canola oil, braising without preliminary frying, and grilling on a rack (avoiding direct flame exposure). Deep-frying in excessive animal or vegetable fat must be categorically avoided. Adherence to these evidence-based dietary principles constitutes the cornerstone of non-pharmacological intervention in gallstone disease, promoting metabolic homeostasis and reducing the frequency of biliary colic episodes.